featured
Long-Term Effectiveness of Adjuvant Treatment With COMT or MAO-B Inhibitors for PD Uncontrolled by Levodopa
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial
JAMA Neurol 2022 Feb 01;79(2)131-140, R Gray, S Patel, N Ives, C Rick, R Woolley, S Muzerengi, A Gray, C Jenkinson, E McIntosh, K Wheatley, A Williams, CE ClarkeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.